Dermata Therapeutics Announces Cosmetic Clinical Results for Tome Foundational Treatment
DRMA Dermata Therapeutics Inc
$0.54 -5.26%
View chart & analysis → - 1Dermata Therapeutics released additional cosmetic clinical study results and photos for Tome Foundational Treatment.
- 231 participants evaluated skin changes after using the product once a week for 4 weeks.
- 3Chairman, President, and CEO Gary Proehl stated that more than 1,000 orders have been received since the product launch.
So what's the key point?
Dermata Therapeutics shared clinical study results and photos from using their cosmetic product. The company reported receiving over 1,000 orders since the product launch.
Source ACCESSWIRE +1 · View original ↗
Nothing hidden: past picks and how they did against the S&P 500.